Cargando…

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis

OBJECTIVE: Various methods, including the indocyanine green (ICG) clearance test, the Child–Turcotte–Pugh score (CTP), model for end-stage liver disease (MELD), and MELD combined with serum sodium concentration (MELD-Na), have been used widely in liver function evaluation in patients with end-stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Xiang-Pu, Zhao, Jing, Chen, Yu, Meng, Fan-Kun, Xu, Bin, Yu, Hong-Wei, Meng, Qing-Hua, Liu, Yan-Min, Zhang, Shi-Bin, Meng, Sha, Zhang, Jing-Yun, Zhang, Jin-Yan, Duan, Zhong-Ping, Zheng, Su-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2016
Materias:	Original Articles: Liver Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777221/ https://www.ncbi.nlm.nih.gov/pubmed/26649802 http://dx.doi.org/10.1097/MEG.0000000000000538

Ejemplares similares

MELD-GRAIL and MELD-GRAIL-Na Are Not Superior to MELD or MELD-Na in Predicting Liver Transplant Waiting List Mortality at a Single-center Level
por: Chetwood, John D., et al.
Publicado: (2022)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Correlation of Model for End Stage Liver Disease (MELD), MELD-Sodium (MELD-Na), and Child-Turcotte-Pugh (CTP) Score With Frailty in Patients With Hepatitis C Virus (HCV) Related Cirrhosis
por: Panezai, Muhammad Qaiser, et al.
Publicado: (2023)

Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
por: Montano-Loza, Aldo J, et al.
Publicado: (2015)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation
por: Lee, Hannah, et al.
Publicado: (2017)

MELD-GRAIL-Na Is a Better Predictor of Mortality Than MELD in Korean Patients with Cirrhosis
por: Kim, Jung-Woo, et al.
Publicado: (2023)

Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era
por: Kushner, Tatyana, et al.
Publicado: (2021)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

Assessment of frailty in cirrhosis using bedside measures and its correlation with Child-Turcotte-Pugh, MELD & MELD-Na Scores
por: Zuberi, Bader Faiyaz, et al.
Publicado: (2022)

Correlation of HVPG Level with CTP Score, MELD Score, Ascites, Size of Varices, and Etiology in Cirrhotic Patients
por: Ramanathan, Subramaniam, et al.
Publicado: (2016)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

The MELD-Plus: A generalizable prediction risk score in cirrhosis
por: Kartoun, Uri, et al.
Publicado: (2017)

Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis
por: Dultz, Georg, et al.
Publicado: (2013)

Liver Transplantation in Patients with Portal Vein Thrombosis: Comparing Pre-MELD and MELD era
por: Saidi, R. F., et al.
Publicado: (2012)

Prognostic Role of MELD-Lactate in Cirrhotic Patients' Short- and Long-Term Prognosis, Stratified by Causes of Cirrhosis
por: Chen, Xiao-Fu
Publicado: (2022)

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2018)

The Usefulness of Mayo End-stage Liver Disease (MELD) and MELD-Sodium (MELD-Na) Scores for Predicting Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
por: Coxeter-Smith, Catherine, et al.
Publicado: (2023)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Alsebaey, Ayman, et al.
Publicado: (2021)

MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
por: Krishnan, Arunkumar, et al.
Publicado: (2023)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score
por: Kaiser, Thorsten, et al.
Publicado: (2017)

In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2018)

The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients
por: Klinzing, Stephanie, et al.
Publicado: (2014)

MELD: Mixed effects for large datasets
por: Nielson, Dylan M., et al.
Publicado: (2017)

The Melding of Drug Screening Platforms for Melanoma
por: Couto, Gabriela Klein, et al.
Publicado: (2019)

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension
por: Paternostro, Rafael, et al.
Publicado: (2018)

Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question
por: Pitton, Michael B., et al.
Publicado: (2020)

Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation
por: Lins, Paulo Ricardo Gessolo, et al.
Publicado: (2022)

Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis
por: Gimenez, Paula, et al.
Publicado: (2018)

Systemic Inflammatory Response Syndrome and MELD Score in Hospital Outcome of Patients with Liver Cirrhosis
por: Behroozian, Ramin, et al.
Publicado: (2012)

Incorporation of frailty estimated by gait speed within MELD-Na and the predictive potential for mortality in cirrhosis
por: Deng, You, et al.
Publicado: (2020)

Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients
por: Li, Xin, et al.
Publicado: (2022)

HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
por: Wang, Yue, et al.
Publicado: (2022)

PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis
por: Burza, Maria Antonella, et al.
Publicado: (2014)

MELD Score Is Not Related to Spontaneous Bacterial Peritonitis
por: Haddad, Luciana, et al.
Publicado: (2015)

Combining chains of Bayesian models with Markov melding
por: Manderson, Andrew A., et al.
Publicado: (2022)

Approaches for patients with very high MELD scores
por: Artru, Florent, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kk1e8l4kn7n6pfm8joqurkp59i